Literature DB >> 21253733

Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis.

Zhenhua Duan1, Faming Pan, Zhen Zeng, Tianchen Zhang, Sheng Wang, Guixing Li, Shengqian Xu, Jianhua Xu, Li Zhang.   

Abstract

Up to now, many publications have evaluated the correlation between IL-23R polymorphisms and ankylosing spondylitis with conflicting results. We perform this meta-analysis to collect all the relevant studies up to date to further clarify the association of IL-23R polymorphisms with AS. Relevant published data were retrieved through Medline, PubMed, Embase, Web of Science, CNKI, Chinese BioMedical Literature Database on disc, and the statistical analysis was conducted using Stata 11.0. (1) A total of 11 literatures, including 13 population samples, were studied. (2) The allele A frequency of rs11209032 was higher in the AS group than in the controls (A vs. G: OR = 1.173, 95% CI = 1.107-1.243, P < 0.001). (3) The allele A of rs1004819 was higher in the AS group than in the controls in both all-pooled population (A vs. G: OR = 1.147, 95% CI = 1.022-1.287, P = 0.02) and Europe-pooled population (A vs. G: OR = 1.199, 95% CI = 1.007-1.429, P = 0.042). (4) The allele frequency T of rs1343151, G of rs10489629, and A of rs11209026 was lower in the AS group than in the controls. (5) No significant differences were found in allele frequency of rs10889677 polymorphism between cases and controls by random effects model. We concluded that the genetic susceptibility for AS is associated with the IL-23R gene polymorphisms. The protective SNPs include rs1343151, rs10489629, and rs11209026 while rs1004819 and rs11209032 may be the susceptibility SNPs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21253733     DOI: 10.1007/s00296-010-1769-7

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis.

Authors:  M A Brown; S H Laval; S Brophy; A Calin
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

2.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

Review 3.  The genetic background of ankylosing spondylitis.

Authors:  Anikó Végvári; Zoltán Szabó; Sándor Szántó; Tibor T Glant; Katalin Mikecz; Zoltán Szekanecz
Journal:  Joint Bone Spine       Date:  2009-12       Impact factor: 4.929

4.  Single-nucleotide polymorphisms and expression of IL23R in Chinese ankylosing spondylitis patients.

Authors:  Xinwei Wang; Jinxian Huang; Zhiming Lin; Zetao Liao; Chao Li; Qiujing Wei; Yingjuan Jiang; Like Zhao; Jieruo Gu
Journal:  Rheumatol Int       Date:  2009-08-19       Impact factor: 2.631

5.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

6.  Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series.

Authors:  Tugce Karaderi; David Harvey; Claire Farrar; Louise H Appleton; Millicent A Stone; Roger D Sturrock; Matthew A Brown; Paul Wordsworth; Jennifer J Pointon
Journal:  Rheumatology (Oxford)       Date:  2009-02-02       Impact factor: 7.580

7.  The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis.

Authors:  B Rueda; G Orozco; E Raya; J L Fernandez-Sueiro; J Mulero; F J Blanco; C Vilches; M A González-Gay; J Martin
Journal:  Ann Rheum Dis       Date:  2008-01-16       Impact factor: 19.103

8.  Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis.

Authors:  Xinwei Wang; Zhiming Lin; Qiujing Wei; Yingjuan Jiang; Jieruo Gu
Journal:  Rheumatol Int       Date:  2009-02-27       Impact factor: 2.631

9.  Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjögren syndrome in Hungarian population samples.

Authors:  E Sáfrány; B Pazár; V Csöngei; L Járomi; N Polgár; C Sipeky; I F Horváth; M Zeher; G Poór; B Melegh
Journal:  Scand J Immunol       Date:  2009-07       Impact factor: 3.487

10.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.

Authors:  John D Reveille; Anne-Marie Sims; Patrick Danoy; David M Evans; Paul Leo; Jennifer J Pointon; Rui Jin; Xiaodong Zhou; Linda A Bradbury; Louise H Appleton; John C Davis; Laura Diekman; Tracey Doan; Alison Dowling; Ran Duan; Emma L Duncan; Claire Farrar; Johanna Hadler; David Harvey; Tugce Karaderi; Rebecca Mogg; Emma Pomeroy; Karena Pryce; Jacqueline Taylor; Laurie Savage; Panos Deloukas; Vasudev Kumanduri; Leena Peltonen; Sue M Ring; Pamela Whittaker; Evgeny Glazov; Gethin P Thomas; Walter P Maksymowych; Robert D Inman; Michael M Ward; Millicent A Stone; Michael H Weisman; B Paul Wordsworth; Matthew A Brown
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

View more
  12 in total

Review 1.  Mediators of inflammation and bone remodeling in rheumatic disease.

Authors:  Anita T Shaw; Ellen M Gravallese
Journal:  Semin Cell Dev Biol       Date:  2015-10-19       Impact factor: 7.727

Review 2.  The associations between PD-1, CTLA-4 gene polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis and systemic review.

Authors:  Si Chen; Yuan Li; Chuiwen Deng; Jing Li; Xiaoting Wen; Ziyan Wu; Chaojun Hu; Shulan Zhang; Ping Li; Xuan Zhang; Fengchun Zhang; Yongzhe Li
Journal:  Rheumatol Int       Date:  2015-08-01       Impact factor: 2.631

Review 3.  An update on the genetics of HLA B27-associated acute anterior uveitis.

Authors:  Tammy M Martin; James T Rosenbaum
Journal:  Ocul Immunol Inflamm       Date:  2011-04       Impact factor: 3.070

4.  Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Inflamm Res       Date:  2011-11-17       Impact factor: 4.575

Review 5.  Endoplasmic reticulum aminopeptidase 1 and interleukin-23 receptor in ankylosing spondylitis.

Authors:  Nigil Haroon
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

Review 6.  Impact of inflammation on the osteoblast in rheumatic diseases.

Authors:  Rebecca Baum; Ellen M Gravallese
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

7.  Association between rs7517847 and rs2201841 polymorphisms in IL-23 receptor gene and risk of ankylosing spondylitis: a meta-analysis.

Authors:  Bin Xu; Jian-Xiong Ma; Xin-Long Ma; Hao-Bo Jia; Rui Feng; Li-Yan Xu
Journal:  PeerJ       Date:  2015-04-23       Impact factor: 2.984

8.  MEFV M694V mutation has a role in susceptibility to ankylosing spondylitis: A meta-analysis.

Authors:  Linqing Zhong; Hongmei Song; Wei Wang; Ji Li; Mingsheng Ma
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

9.  Association of rs11209032 and rs1004819 Polymorphisms in Interleukin-23 Receptor Gene With Ankylosing Spondylitis.

Authors:  Müjgan Özdemir Erdoğan; Tuğba Şule Çankaya; Alper Murat Ulaşli; Saliha Handan Yildiz; Evrim Suna Arikan Terzi; Tuba Çavdar; Ümit Dündar; Mustafa Solak
Journal:  Arch Rheumatol       Date:  2016-04-06       Impact factor: 1.472

10.  Serum IL-6 and IL-23 Levels and Their Correlation with Angiogenic Cytokines and Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome.

Authors:  Hanna Przepiera-Będzak; Katarzyna Fischer; Marek Brzosko
Journal:  Mediators Inflamm       Date:  2015-08-03       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.